Hypercalcemia: Difference between revisions
From IDWiki
(Imported from text file) |
(linkified) |
||
Line 1: | Line 1: | ||
== |
== Background == |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*** HHM (PTHrP): squamous cell carcinomas |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
==Differential Diagnosis== |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
***[[Humoural hypercalcemia of malignancy]] (HHM): mediated by PTHrP, and most common in [[Squamous cell carcinoma|squamous cell carcinomas]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Endocrinology]] |
[[Category:Endocrinology]] |
Latest revision as of 13:01, 2 August 2020
Background
Pathophysiology
- Vitamin D is absorbed from GI tract
- First hydroxylation to 25-OH vitamin D in liver
- Second hydroxylation to 1,2-OH vitamin D in kidneys by alpha-1 hydroxylase
- PTH from parathyroid glands
- Calcitriol is involved somewhere
Differential Diagnosis
- High PTH
- Low PTH
- Malignancy
- Humoural hypercalcemia of malignancy (HHM): mediated by PTHrP, and most common in squamous cell carcinomas
- alpha-1 hydroxylase: lymphoma
- Local osteolysis: multiple myeloma
- Bony metastases: breast cancer
- Granulomatous disease (alpha-1 hydroxylase)
- Nutritional
- Thyrotoxicosis
- Prolonged immobilization
- Malignancy